GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Kymera Therapeutics rises 2.82% in Friday's session

Published by Global Banking & Finance Review

Posted on November 6, 2026

1 min read
Add as preferred source on Google
KYMR 131.73 +2.82% last traded price, 6 Nov 2026
Previous close
128.12
Market cap
—

The figures in this article were checked against this snapshot before publication.

Kymera Therapeutics shares last traded at 131.73 USD, 2.82% above their previous close of 128.12 USD in the United States health care sector on 6 November 2026.

Last traded price131.73 USD
Previous close128.12 USD
Change from the previous close+2.82%

Prices of Kymera Therapeutics (KYMR), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 6 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 5 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares or US$5 million traded in the previous session. How we compile these reports.

Kymera Therapeutics — daily KYMR Delayed

Related Articles

More from Markets

Explore more articles in the Markets category